Integrated Assessment Of Marketing Applications And Integrated Review Documentation Workshop

Summary

The Food and Drug Administration (FDA) held a public This webinar discussed how and when to work with FDA to improve your Submit proposed questions on this poster to DMFWorkshop2021 by March 19, 2021, and tune in for the subsequent ... Rakhi Shah, CDER Office of Pharmaceutical Quality, discusses This presentation provided a brief discussion on the impact of GDUFA III Prior Geoffrey Wu from CDER's Office of Pharmaceutical Quality shares key challenges during quality Maureen Dillon-Parker provides an overview of the contents and format of the Investigational New Drug This session discussed the risk-based regulatory CDER's Paul Gouge, JD, provides background on Investigational New Drug (IND) safety reporting and describes the new ...